Please use this identifier to cite or link to this item: https://scholarbank.nus.edu.sg/handle/10635/160614
DC FieldValue
dc.titleASSESSMENT OF SOME FRUSEMIDE TABLETS AVAILABLE IN SINGAPORE
dc.contributor.authorLIM SHIU CHIN
dc.date.accessioned2019-10-18T06:57:23Z
dc.date.available2019-10-18T06:57:23Z
dc.date.issued1986
dc.identifier.citationLIM SHIU CHIN (1986). ASSESSMENT OF SOME FRUSEMIDE TABLETS AVAILABLE IN SINGAPORE. ScholarBank@NUS Repository.
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/160614
dc.description.abstractThe physico-chemical and pharmacclogical characteristics of frusemide will be discussed in Section One. Quality control test including the B.P. assay of drug content, the B.P. uniformity of weight test, B.P. uniformity of diameter and disintegration test were carried out on the six chosen brands of frusemide tablet marketed in Singapore. The generic products were manufactured locally, whereas another four proprietary products were imported from Malaysia, Germany and Australia. All the six products tested met the B.P. weight uniformity test and disintegration test. Only Diurin '40' failed the uniformity of diameter test, nevertheless, it is the only product that passed B.P. assay of drug content. A wide range of hardness and friability values were observed among these products. Statistical evaluation of result were carried out and it was shown that the six brands were not chemical equivalent although they have the same label-claimed fruscmide content.
dc.sourceCCK BATCHLOAD 20191016
dc.subjectFurosemide Standards
dc.typeThesis
dc.contributor.departmentPHARMACY
dc.contributor.supervisorGORDON BECKET
dc.contributor.supervisorLUCY WAN
dc.description.degreeBachelor's
dc.description.degreeconferredBACHELOR OF SCIENCE (PHARMACY) (HONOURS)
Appears in Collections:Bachelor's Theses

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
b13765000.PDF3.55 MBAdobe PDF

RESTRICTED

NoneLog In

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.